Scientific Program

DAY 1 (February 22, Mon) DAY 2 (February 23, Tue)
09:15-09:55 Plenary 1: siRNA Therapeutics
09:15-09:55 PL01 Mano Manoharan (Alnylam Pharmaceuticals, USA)
09:55-11:10 Session 1. siRNA Therapeutics
09:55-10:20 S01-1 Takeshi Wada (Tokyo University of Science, Japan)
10:20-10:45 S01-2 Jihye Park (Novo Nordisk GNAT, USA)
10:45-11:10 S01-3 June Hyun Park (OliX Pharmaceuticals, Korea)
11:30-12:35 Session 2. mRNA Therapeutics: Innovation & Production
11:30-11:45

S02-1 Chemical Engineering of mRNA for Enhanced Translation and Therapeutic Performance

Young Jun Seo (Elonova, Korea)
11:45-12:10 S02-2 Hiroshi Abe (Nagoya University, Japan)
12:10-12:35 S02-3 TBD (Samyang Biopharm, Korea)
13:35-14:15 Plenary 2: RNA Biology
13:35-14:15

PL02 Noncanonical Tails: Functions, Mechanisms, and Therapeutic Potential

V. Narry Kim (Seoul National University, Korea)
14:15-15:35 Session 3. RNA Biology & Chemistry
14:15-14:40

S03-1 Potent and Specific siRNA Design: From Sequence Rules to Structure-Guided Precision Therapeutics

Kumiko Ui-Tei (Institute of Science Tokyo, Japan)
14:40-14:55 S03-2 Yoosik Kim (KAIST, Korea)
14:55-15:10 S03-3 Jinha Yu (Ewha Womans University, Korea)
15:10-15:35 S03-4 TBD
15:55-17:25 Session 4. Innovation in Oligonucleotide Therapeutics
15:55-16:20 S04-1 Ron Batra (Dyne Therapeutics, USA)
16:20-16:35

S04-2 Chemical Engineering of mRNA for Enhanced Translation and Therapeutic Performance

Dae-Ro Ahn (KIST, Korea)
16:35-17:00 S04-3 Long-Cheng Li (Ractigen Therapeutics, China)
17:00-17:25 S04-4 TBD
TOP